Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $121.0000 (0.87%) ($118.6000 - $121.4400) on Tue. Jun. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 46 | Latest Price | $121.0000(0.87%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(35%) IBB(30%) VFMO(29%) VYM(29%) XBI(29%) | Factors Impacting UTHR price | UTHR will decline at least -1.02% in a week (0% probabilities). VIXM(-19%) VXX(-15%) UUP(-11%) XLC(-7%) TLT(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $121.24(-0.2%) | 10 Day Moving Average | $119.85(0.96%) | 20 Day Moving Average | $120.04(0.8%) | To recent high | -3.8% | To recent low | 30.5% | Market Cap | $5.367b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |